Jonatan C. S. de Carvalho

发表

Cholinergic and lipid mediators crosstalk in Covid-19 and the impact of glucocorticoid therapy

C. Fuzo, C. Sorgi, L. Faccioli, 2021, medRxiv.

Matrix Metalloproteinases on Severe COVID-19 Lung Disease Pathogenesis: Cooperative Actions of MMP-8/MMP-2 Axis on Immune Response through HLA-G Shedding and Oxidative Stress

J. Tanus-Santos, R. F. Gerlach, E. Donadi, 2022, Biomolecules.

Acetylcholine, Fatty Acids, and Lipid Mediators Are Linked to COVID-19 Severity

C. Fuzo, C. Sorgi, L. Faccioli, 2022, The Journal of Immunology.

The Severity of COVID-19 Affects the Plasma Soluble Levels of the Immune Checkpoint HLA-G Molecule

E. Donadi, C. Sorgi, L. Faccioli, 2022, International journal of molecular sciences.

The Interplay among Glucocorticoid Therapy, Platelet-Activating Factor and Endocannabinoid Release Influences the Inflammatory Response to COVID-19

C. Fuzo, C. Sorgi, L. Faccioli, 2023, Viruses.

sTREM-1 Predicts Disease Severity and Mortality in COVID-19 Patients: Involvement of Peripheral Blood Leukocytes and MMP-8 Activity

C. Fuzo, C. Sorgi, L. Faccioli, 2021, Viruses.

The turning point of COVID‐19 severity is associated with a unique circulating neutrophil gene signature

C. Fuzo, C. Sorgi, L. Faccioli, 2023, Immunology.

Prognostic value of sTREM-1 in COVID-19 patients: a biomarker for disease severity and mortality

C. Sorgi, L. Faccioli, I. K. Santos, 2020, medRxiv.

Anandamide reduces the migration of lymphocytes to the intestine BY CB2 activation and reduces TNF-α in the target organs, protecting mice from graft-versus-host disease.

C. Sorgi, M. Rachid, V. Pinho, 2023, European journal of pharmacology.

Plasma Sphingomyelin Disturbances: Unveiling Its Dual Role as a Crucial Immunopathological Factor and a Severity Prognostic Biomarker in COVID-19

C. Fuzo, C. Sorgi, L. Faccioli, 2023, Cells.